Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership

 
 

Intellipharmaceutics International Inc. (IPCI) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions of CAD, except per share itemsNov-30-21Nov-30-20Nov-30-19Nov-30-18Nov-30-17Nov-30-16Nov-30-15Nov-30-14
Revenues0.01.43.51.75.52.24.18.8
            Revenue growth-100.0%-59.7%103.2%-68.9%145.0%-45.1%-53.3%474.1%
Cost of goods sold0.7-8.00.00.10.70.00.00.0
Gross profit-0.79.43.41.64.82.24.18.8
            Gross margin 673.5%99.0%92.7%87.2%100.0%100.0%100.0%
Selling, general and administrative1.22.14.23.53.33.53.63.9
Research and development2.73.56.610.89.38.27.28.0
EBIT-4.7-4.7-7.8-13.3-8.3-9.9-7.1-3.5
            EBIT margin -336.8%-225.1%-778.1%-150.2%-438.4%-173.8%-40.3%
Pre-tax income-5.3-3.4-8.1-13.7-8.9-10.1-7.4-3.9
Income taxes-5.13.48.10.00.00.00.00.0
            Tax rate97.8%  0.0%0.0%0.0%0.0%0.0%
Net income-5.1-3.4-8.1-13.7-8.9-10.1-7.4-3.9
            Net margin -241.9%-232.3%-802.7%-160.9%-451.4%-181.7%-44.0%
 
Diluted EPS($0.17)($0.14)($0.37)($2.89)($2.86)($3.80)($0.31)($0.17)
Shares outstanding (diluted)29.423.621.64.83.12.723.823.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy